<unk>  is the most common form of chronic anovulation associated with androgen excess.<unk>  occurs in approximately 5% to 10% of reproductive-age women. The diagnosis of<unk>  is made by excluding other hyper androgenic disorders like non-classic adrenal hyperplasia, androgen-secreting tumors, hyperprolactinemia in women with chronic anovulation and androgen excess.<unk>  can be diagnosed whenever two of following three criteria are present oligomenorrhea, hirsutism and/or hyperandrogenemia and<unk> <unk> es. Prompt investigation and treatment is necessary for patients with excessive vaginal bleeding. The endometrium of the patient with<unk>  must be evaluated by biopsy because of long-term exposure to unopposed estrogen leaves patients at increased risk for endometrial cancer.<unk>  is also associated with increased metabolic and cardiovascular disorders.<unk>  is considered to be a heterogeneous disorder with multifactorial causes.<unk>  risk is significantly increased with a<unk> itive family history of chronic anovulation and androgen excess, and this complex disorder may be inherited in a polygenic fashion. Treatment begins with weight loss and metformin, if either or both are indicated, and depending on the patient's reproductive needs oral contraception supplemented with antiandrogen therapy for patients not wishing to conceive or fertility treatments for patients desiring pregnancy. The prognosis is excellent with treatment. Complications of<unk>  include infertility, irregular uterine bleeding, and increased pregnancy loss
Polycystic ovary syndrome
Secondary amenorrhea
Anovulation
Primary amenorrhea
Premature ovarian failure
Asherman's syndrome
Hyperprolactinemia
Hysteria